Laura Price (London, United Kingdom), Alice Huertas (Paris, France), David Jiménez Castro (Madrid, Spain), Andrew Peacock (Glasgow, United Kingdom)
Spontaneous flow increase from implantable pump for intravenous treprostinil delivery
Frédéric Lador (Geneva, Switzerland), Garance Kopp, Anne-Lise Hachulla, Stéphane Noble, Paola M. Soccal, Maurice Beghetti, Frédéric Lador
|   |
PSGR olfactory receptor: A new potential target in pulmonary arterial hypertension
Audrey Courboulin (Le Plessis-Robinson, France), Audrey Courboulin, Marceau Quatredeniers, Guenhaël Sanz, Sandra Breuils-Bonnet, Matthieu Vocelle, Mathilde Lafond, Frédéric Perros, Sébastien Bonnet, Edit Pajot-Augy, Marc Humbert, Sylvia Cohen-Kaminsky
| |
Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Aaron Waxman (Boston, United States of America), Sergio Segrera, Alexander Opotowsky, Laurie Lawler, David Systrom, Aaron Waxman
| |
Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells
Zhuoli Zhang (Beijing, China), Yong Fan (Beijing, China), Zhuoli Zhang, Lan Gao, Yong Fan, Yanjie Hao, Wei Zhou
| |
Pulmonary arterial hypertension associated with several mutations
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Adolfo Baloira, Diana Valverde
| |
Neutrophil- to-lymphocyte ratio as a prognostic parameter in pulmonary arterial hypertension
Vasile Foris (Graz, Austria), Vasile Foris, Gabor Kovacs, Philipp Douschan, Alexander Avian, Andrea Olschewski, Horst Olschewski
| |
Diagnostic utility of the physical examination for pulmonary hypertension
Kevin Solverson (Calgary, Canada), Kevin Solverson, Daniel Vis, Micheal Braganza, Jeff Shaw, Luke Rannelli, Mitesh Thakrar, Rhea Varughese, Naushad Hirani, Doug Helmersen, Jason Weatherald
| |
Intravenous prostacyclin for pulmonary hypertension: Patient’s perspective on complications
Sara Tyebally (London, United Kingdom), Sara Tyebally, Ann Sturdy, Arif Khokhar, Lisa Parfitt, Carl Harries, Laura Price, John Wort, Rafa Alonso, Kostas Dimopoulos, Michael Gatzoulis
| |
Argon reduces the ET-1 induced increase of segmental PVR and the generation of lung edema
Annette Rieg (Aachen, Germany), Said Suleiman, Mark Coburn, Julia Krabbe, Rolf Rossaint, Christian Martin, Annette Rieg
| |
Role of survivin in experimental models of pulmonary arterial hypertension
Isabel Blanco (Barcelona, Spain), Isabel Blanco, Elisabet Ferrer, Susana Maqueda, Tanja Paul, Neus Luque, Olga Tura-Ceide, Victor Ivo Peinado, Joan Albert Barbera
| |
Clinical manifestations and genetic background in Japanese patients with hereditary haemorrhagic telangiectasia
Kunihiko Yoshimura (Tokyo, Japan), Kunihiko Yoshimura, Takafumi Ito, Hiromi Aono
| |
Inhaled INS1009 demonstrates localized pulmonary vasodilation activity
Zhili Li (Bridgewater, United States of America), Zhili Li, Richard Chapman, Vladimir Malinin, Michel Corboz, Adam Plaunt, Charles Laurent, Han Yin, Dan Salvail, Walter Perkins
| |
Analysis of BMPR2 gene expression in B-lymphocytes of pulmonary arterial hypertension patients
Guillermo Pousada (Vigo, Spain), Guillermo Pousada, Mauro Lago, Sonia Prado-López, Adolfo Baloira, Rubén Varela-Calviño, Diana Valverde
| |
Centrilobular nodules are combined with lack of PFO and worse haemodynamic profile in IPAH patients
Monika Szturmowicz (Warsaw, Poland), Monika Szturmowicz, Aneta Kacprzak, Marcin Kurzyna, Barbara Burakowska, Adam Torbicki
| |
Hemorrhagic complications of treatment in patients with pulmonary embolism
Jacinto Hernandez Borge (Badajoz, Spain), Pedro Pires Goncalves, Jacinto Hernandez Borge, Maria del Carmen Garcia Garcia, Maria Jose Antona Rodriguez, Isabel Asschert Aguero, Amparo Sanz Cabrera, Miguel Benitez-Cano Gamonoso, Pilar Cordero Montero, Ignacio Rodriguez Blanco, Francisca Lourdes Marquez Perez
| |
Evaluation of predictors of early and late mortality in 414 acute pulmonary embolism patients
Abdulsamet Sandal (Ankara, Turkey), Abdulsamet Sandal, Elif Tugce Korkmaz, Funda Aksu, Deniz Köksal, Ziya Toros Selçuk, Ahmet Ugur Demir, Salih Emri, Lütfi Çöplü
| |
Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Velin Stratev (Varna, Bulgaria), Velin Stratev, Valentina Dimitrova, Tanya Dobreva, Diana Petkova
| |
Fractional exhaled nitric oxide in pulmonary hypertension
Hala El Chami (Boston, United States of America), Hala El Chami, Cheryl Fortier, Rosemary Tsacoyianis, Kari Roberts, Nicholas Hill, Ioana Preston
| |
Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence
Serhat Erol (Ankara, Turkey), Serhat Erol, Aslihan Gurun, Fatma Ciftci, Aydin Ciledag, Akin Kaya, Elif Sen, Gokhan Celik, Ismail Savas
| |